TILT Biotherapeutics
- Biotech or pharma, therapeutic R&D
TILT Biotherapeutics (Tiltbio) is a clinical-stage biotechnology company creating the next generation of immunotherapies for solid tumors.
Tiltbio is reshaping cancer treatment by developing innovative investigational therapies that are intended to offer hope to patients with limited treatment options, with an initial focus on platinum-resistant ovarian cancer.
The patented TILT® technology delivers modified viruses intravenously to cancer cells, helping the immune system recognize and attack solid tumors. Intravenous delivery offers the efficiency of the TILT® technology reaching the whole body, potentially targeting primary and metastatic tumors.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}